Hallmarks of cancer: the next generation
- PMID: 21376230
- DOI: 10.1016/j.cell.2011.02.013
Hallmarks of cancer: the next generation
Abstract
The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Rho GTPases modulate malignant transformation of tumor cells.Small GTPases. 2014;5:e29019. doi: 10.4161/sgtp.29019. Epub 2014 May 8. Small GTPases. 2014. PMID: 25036871 Free PMC article. Review.
-
The contribution of tumour-derived exosomes to the hallmarks of cancer.Crit Rev Clin Lab Sci. 2016;53(2):121-31. doi: 10.3109/10408363.2015.1092496. Epub 2015 Oct 19. Crit Rev Clin Lab Sci. 2016. PMID: 26479834 Review.
-
Hallmarks of Cancers: Primary Antibody Deficiency Versus Other Inborn Errors of Immunity.Front Immunol. 2021 Aug 17;12:720025. doi: 10.3389/fimmu.2021.720025. eCollection 2021. Front Immunol. 2021. PMID: 34484227 Free PMC article. Review.
-
Tumor-stroma crosstalk: targeting stroma in breast cancer.Curr Opin Oncol. 2014 Nov;26(6):551-5. doi: 10.1097/CCO.0000000000000122. Curr Opin Oncol. 2014. PMID: 25279962 Review.
-
Long non-coding RNAs in cancer: Another layer of complexity.J Gene Med. 2019 Jan;21(1):e3065. doi: 10.1002/jgm.3065. Epub 2019 Jan 8. J Gene Med. 2019. PMID: 30549380 Review.
Cited by
-
MACC1 revisited - an in-depth review of a master of metastasis.Biomark Res. 2024 Nov 23;12(1):146. doi: 10.1186/s40364-024-00689-4. Biomark Res. 2024. PMID: 39580452 Free PMC article. Review.
-
Mitochondrial heteroplasmy improves risk prediction for myeloid neoplasms.Nat Commun. 2024 Nov 22;15(1):10133. doi: 10.1038/s41467-024-54443-3. Nat Commun. 2024. PMID: 39578475 Free PMC article.
-
PCK1 as a target for cancer therapy: from metabolic reprogramming to immune microenvironment remodeling.Cell Death Discov. 2024 Nov 22;10(1):478. doi: 10.1038/s41420-024-02240-8. Cell Death Discov. 2024. PMID: 39578429 Free PMC article. Review.
-
Single-cell analysis uncovers liver susceptibility to pancreatic cancer metastasis via myeloid cell characterization.Discov Oncol. 2024 Nov 22;15(1):696. doi: 10.1007/s12672-024-01566-0. Discov Oncol. 2024. PMID: 39578286 Free PMC article.
-
Research advances in branched-chain amino acid metabolism in tumors.Mol Cell Biochem. 2024 Nov 22. doi: 10.1007/s11010-024-05163-1. Online ahead of print. Mol Cell Biochem. 2024. PMID: 39576465 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases